Dr Reddy’s Labs informed exchanges that the Regulatory Authority of Germany (Regierung von Oberbayern), concluded an audit of formulations manufacturing facility in Duvvada, Vishakapatnam, with zero critical and six major observations.
Products manufactured at the facility are not currently exported to the European Union.
The company will be submitting a corrective and preventive action plan (CAPA) to the authorities.
The facility’s compliance with the CAPA and other applicable regulations will be reviewed again by the regulator by November 2018 for continuation of EU-GMP certification.
For more information ✆ – 0731-6642300 or Visit http://www.epicresearch.co
You may also like:
|Sensex, Nifty rangebound; RBI’s MPC meet outcome awaited||Sensex, Nifty continue to be sluggish ahead of RBI policy; Europe mixed|